This journal focuses on the discovery and development of anti-cancer drugs and therapies. It covers research on novel drug delivery systems, including nanoparticles, liposomes, and exosomes, aimed at overcoming drug resistance and improving bioavailability. The scope also includes investigations into specific molecular targets, signaling pathways, and genetic factors involved in various cancers, as well as the exploration of combination therapies and the potential of natural compounds and their derivatives as anti-cancer agents. The journal also features analyses of patent landscapes and technological trajectories in cancer drug discovery.
Diverse Scientific and Economic StudiesLegal Cases and CommentaryIntellectual Property and PatentsCancer Mechanisms and TherapyFerroptosis and cancer prognosisCancer, Hypoxia, and MetabolismCancer Research and TreatmentCancer Research and Treatments14-3-3 protein interactionsNanoparticle-Based Drug Delivery